SCHEMBL7965609

SCHEMBL7965609

CCN(Cc1ccccc1)C(C)CCC(C#N)(c1ccc(C(F)(F)F)c(C(F)(F)F)c1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EBP Q15125 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
BCHE P06276 1/20 0.38
AR P10275 2/20 0.33
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
CYP3A4 P08684 6/20 0.33
ABCB1 P08183 6/20 0.33
ABCC1 P33527 3/20 0.33
TSHR P16473 3/20 0.33
LMNA P02545 3/20 0.33
CYP2C19 P33261 2/20 0.33
MEN1 O00255 2/20 0.33
ABCB11 O95342 2/20 0.33
KMT2A Q03164 2/20 0.33
KCNH2 Q12809 2/20 0.33
HTT P42858 2/20 0.33
SLC22A1 O15245 1/20 0.33
CACNA1F O60840 1/20 0.33
CHRM2 P08172 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974383 0.92 SIGMAR1 (0.40) EBPSIGMAR1BCHEARUBE2M
SCHEMBL7967158 0.89 BCHE (0.41) EBPSIGMAR1BCHEUBE2MDCUN1D1
SCHEMBL7965705 0.89 SIGMAR1 (0.45) EBPSIGMAR1BCHEUBE2MDCUN1D1
SCHEMBL7968588 0.88 EBP (0.43) EBPSIGMAR1ARUBE2MDCUN1D1
SCHEMBL7971484 0.87 EBP (0.40) EBPSIGMAR1ARUBE2MDCUN1D1
SCHEMBL7956198 0.86 EBP (0.40) EBPSIGMAR1BCHEUBE2MDCUN1D1
SCHEMBL7971696 0.85 EBP (0.39) EBPSIGMAR1BCHEARUBE2M
SCHEMBL7967041 0.85 BCHE (0.39) EBPSIGMAR1BCHEUBE2MDCUN1D1
SCHEMBL7966979 0.84 SIGMAR1 (0.45) EBPSIGMAR1BCHECYP3A4ABCB1
SCHEMBL7972289 0.84 EBP (0.40) EBPSIGMAR1BCHEUBE2MDCUN1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265439-B1 Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives G.D. SEARLE & CO. 2001-07-24 US disclosed